You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

List of Excipients in API sertraline


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing sertraline

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
ROERIG ZOLOFT sertraline hydrochloride 0049-4960 ALUMINUM OXIDE
ROERIG ZOLOFT sertraline hydrochloride 0049-4960 CELLULOSE, MICROCRYSTALLINE
ROERIG ZOLOFT sertraline hydrochloride 0049-4960 D&C YELLOW NO. 10
ROERIG ZOLOFT sertraline hydrochloride 0049-4960 DIBASIC CALCIUM PHOSPHATE DIHYDRATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing sertraline

Company Ingredient NDC Excipient
NCS HealthCare of KY LLC dba Vangard Labs sertraline 0615-7989 ANHYDROUS DIBASIC CALCIUM PHOSPHATE
NCS HealthCare of KY LLC dba Vangard Labs sertraline 0615-7989 CELLULOSE, MICROCRYSTALLINE
NCS HealthCare of KY LLC dba Vangard Labs sertraline 0615-7989 D&C YELLOW NO. 10
NCS HealthCare of KY LLC dba Vangard Labs sertraline 0615-7989 FD&C BLUE NO. 1
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for sertraline

Excipient focus: ALCOHOL

Excipient focus: ALUMINUM OXIDE

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BUTYLATED HYDROXYTOLUENE

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CI 42090

Excipient focus: CI 77891

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: D&C YELLOW NO. 10

Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE

Excipient focus: FD&C BLUE NO. 1--ALUMINUM LAKE

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C BLUE NO. 2 ALUMINUM LAKE

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 5

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: GLYCERIN

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

Excipient focus: HYDROXYPROPYL METHYLCELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MENTHOL

Excipient focus: METHYLCELLULOSE

Excipient focus: MICROCRYSTALLINE CELLULOSE

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

Excipient focus: PEG-20 SORBITAN OLEATE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: VANILLIN

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group